Fenilefrina Aguettant

Fenilefrina Aguettant is a pharmaceutical product containing phenylephrine, used for intravenous administration. It is commonly associated with cardiovascular support and vasoconstriction. This medication is manufactured by Laboratoire Aguettant in the EU.

Fenilefrina Aguettant, containing phenylephrine, is typically used to support cardiovascular function and promote vasoconstriction. It may be administered in clinical settings to manage conditions related to blood pressure and circulation. Phenylephrine is often utilized for its ability to stimulate alpha-adrenergic receptors, which can help in maintaining blood pressure levels.

When administered intravenously, Fenilefrina Aguettant may cause effects such as increased blood pressure and reduced blood flow to certain areas. These effects are generally related to its action on the cardiovascular system. Users may experience a temporary increase in heart rate or changes in blood pressure.

Fenilefrina Aguettant should be handled with care and administered under professional supervision. It is important to follow the prescribed guidelines for intravenous use. Patients with certain cardiovascular conditions should consult their healthcare provider before use.

Fenilefrina Aguettant may interact with other medications, particularly those affecting blood pressure or heart rate. It is advisable to inform healthcare providers about all current medications to avoid potential interactions. Alcohol and certain supplements may also influence the effects of phenylephrine.